This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Eirgen Pharma Ltd.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Praful Balavant Deshpande: Innovator in Pediatric Dosage Forms
Introduction
Praful Balavant Deshpande is a notable inventor based in Waterford, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of pediatric dosage forms. With a total of three patents to his name, Deshpande's work focuses on improving the administration of vitamin D compounds for children.
Latest Patents
Deshpande's latest patents include innovative methods for creating pediatric and modified release dosage forms of vitamin D compounds. These patents detail the processes of making and using these dosage forms, which are crucial for ensuring that children receive the appropriate amounts of essential vitamins in a safe and effective manner.
Career Highlights
Deshpande is currently employed at Eirgen Pharma Ltd., where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the pharmaceutical industry, particularly in the area of pediatric medicine.
Collaborations
Some of his notable coworkers include Stephen James Quinlan and Marta Golec, who contribute to the collaborative environment at Eirgen Pharma Ltd. Their combined expertise enhances the innovative capabilities of the team.
Conclusion
Praful Balavant Deshpande's contributions to pediatric dosage forms represent a significant advancement in pharmaceutical science. His dedication to improving children's health through innovative solutions is commendable and impactful.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile